176 related articles for article (PubMed ID: 9345378)
1. Primary progressive multiple sclerosis: a distinct syndrome?
McDonnell GV; Hawkins SA
Mult Scler; 1996 Oct; 2(3):137-41. PubMed ID: 9345378
[TBL] [Abstract][Full Text] [Related]
2. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
3. Progressive multiple sclerosis: characteristics and management.
Hawker K
Neurol Clin; 2011 May; 29(2):423-34. PubMed ID: 21439451
[TBL] [Abstract][Full Text] [Related]
4. Classification, diagnosis, and differential diagnosis of multiple sclerosis.
Katz Sand I
Curr Opin Neurol; 2015 Jun; 28(3):193-205. PubMed ID: 25887774
[TBL] [Abstract][Full Text] [Related]
5. [Overview of the clinical forms of multiple sclerosis in Japan].
Fukazawa T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1192-4. PubMed ID: 12784703
[TBL] [Abstract][Full Text] [Related]
6. Early recognition and diagnosis of multiple sclerosis.
Waubant E
J Clin Psychiatry; 2012 Apr; 73(4):e14. PubMed ID: 22579157
[TBL] [Abstract][Full Text] [Related]
7. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Antel J; Antel S; Caramanos Z; Arnold DL; Kuhlmann T
Acta Neuropathol; 2012 May; 123(5):627-38. PubMed ID: 22327362
[TBL] [Abstract][Full Text] [Related]
8. Clinical Course of Multiple Sclerosis.
Klineova S; Lublin FD
Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29358317
[TBL] [Abstract][Full Text] [Related]
9. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
[TBL] [Abstract][Full Text] [Related]
10. [Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients].
Sekkat Z; Ongagna JC; Collongues N; Fleury M; Blanc F; de Seze J;
Rev Neurol (Paris); 2012 Apr; 168(4):338-43. PubMed ID: 22341991
[TBL] [Abstract][Full Text] [Related]
11. New multiple sclerosis phenotypic classification.
Lublin FD
Eur Neurol; 2014; 72 Suppl 1():1-5. PubMed ID: 25278115
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of multiple sclerosis subtypes: implications for treatment.
Bitsch A; Brück W
CNS Drugs; 2002; 16(6):405-18. PubMed ID: 12027786
[TBL] [Abstract][Full Text] [Related]
13. Secondary progressive multiple sclerosis: current knowledge and future challenges.
Rovaris M; Confavreux C; Furlan R; Kappos L; Comi G; Filippi M
Lancet Neurol; 2006 Apr; 5(4):343-54. PubMed ID: 16545751
[TBL] [Abstract][Full Text] [Related]
14. Immunological differences between classical phenothypes of multiple sclerosis.
Iwanowski P; Losy J
J Neurol Sci; 2015 Feb; 349(1-2):10-4. PubMed ID: 25586536
[TBL] [Abstract][Full Text] [Related]
15. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and management of multiple sclerosis in children].
Xiong H; Zhang YH; Zhou R; Bao XH; Jiang YW; Wu Y; Wang S; Chang XZ; Fu SQ; Qin J; Wu XR
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):568-73. PubMed ID: 18021526
[TBL] [Abstract][Full Text] [Related]
18. The clinical course of multiple sclerosis.
Confavreux C; Vukusic S
Handb Clin Neurol; 2014; 122():343-69. PubMed ID: 24507525
[TBL] [Abstract][Full Text] [Related]
19. Predicting and preventing the future: actively managing multiple sclerosis.
Hutchinson M
Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055
[TBL] [Abstract][Full Text] [Related]
20. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
Hohol MJ; Orav EJ; Weiner HL
Mult Scler; 1999 Oct; 5(5):349-54. PubMed ID: 10516779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
